@Yale_CRIT -
May 21

ICYMI .@AOC cited @cmorten2's analysis of validity and Gilead's infringement of @CDCgov's patents for HIV PrEP in Thursday's HOC hearing, Billions in Corporate Profits after Millions in Taxpayer Investments @YaleGHJP @akapczynski @gregggonsalves @jsross119 https://t.co/tr5CEvq9qy https://t.co/WwksVW6e2o

@Yale_CRIT -
May 13

RT @JoshuaDWallach: Q: When drugs are approved by FDA w/o postmarketing requirements or commitments, how often do pharma companies voluntar…

@Yale_CRIT -
May 13

RT @AudreyDZhang: So honored to have been chosen for a Lipkin Award here at my first @SocietyGIM meeting - couldn't have done it without an…

@Yale_CRIT -
May 13

RT @jsross119: Huge congratulations to @AudreyDZhang, winner of the #SGIM19 Lipkin Award!! Representing the great work being done @Yale_CRI…

CRIT Program Mission Statement

To promote health by improving the integrity and transparency of biomedical and clinical research

About the CRIT Program

The Collaboration for Research Integrity and Transparency (CRIT) is an inter-disciplinary initiative launched in 2016 to enhance the quality and transparency of the research base for medical products. Through research, advocacy, and litigation, CRIT is focused on ensuring that the clinical evidence that supports and informs our understanding of the safety and effectiveness of pharmaceuticals, medical devices, and other medical products is accurate, comprehensive, accessible, and reliable. The lack of transparency and integrity in clinical research has had serious consequences for patient and clinicians. Current legal structures and research practices are not adequate and efforts to understand and improve clinical research transparency and reporting are needed.

By influencing stakeholders engaged in the clinical research process and in translating these findings for clinical care, CRIT will focus and magnify the impact of our and others’ scholarship, policy analysis and legal action, advancing the field of research integrity, open science, and informing public discourse.

CRIT aims to

  • Achieve a legal and regulatory environment that promotes rigorous clinical research and supports regulatory and clinical decisions that are grounded in high-quality research and accessible data and results.
  • Strengthen the integrity of research of medical products by ensuring that data is both rigorous and reliable, and by facilitating public access to and independent analysis of clinical trial data and results.
  • Conduct legal, public health and health policy research that identifies strengths and weakness of our existing system for facilitating evidence generation and transparency, and developing and evaluating alternative approaches
  • Provide the public and key policymakers with tools that enhance and facilitate open access to data, research results, and other relevant information about medical products.



Contact Katherine Lawton at CRIT.admin@yale.edu if you are interested in joining our email list 

Contact Us

For more information or to join our mailing list, contact Katherine Lawton, Program Coordinator, at crit.admin@yale.edu or call (203) 436-8420

Mailing Address:

c/o Yale Law School
Collaboration for Research Integrity & Transparency
157 Church Street 17th Floor
New Haven, CT 06510-2100


Follow us on Twitter